Literature DB >> 10549635

Nitric oxide synthase-II is expressed in severe corneal alkali burns and inhibits neovascularization.

F Sennlaub1, Y Courtois, O Goureau.   

Abstract

PURPOSE: Inducible nitric oxide synthase (NOS-II) is expressed in many inflammatory conditions. The implication of nitric oxide (NO) in angiogenesis remains controversial. The role of NOS-II and its influence on angiogenesis in corneal neovascularization is unknown and was investigated in this study.
METHODS: A mouse model of corneal neovascularization induced by chemical cauterization was used. NOS-II mRNA expression was analyzed by reverse transcriptase-polymerase chain reaction, and NOS-II protein was studied in situ by immunohistochemical analysis of the cornea. The influence of NOS-II on neovascularization was determined by comparison of vessel development in "normal" wild-type mice and mice with a targeted disruption of the NOS-II gene.
RESULTS: NOS-II mRNA was induced to very high levels after corneal cauterization and remained upregulated throughout the disease. Migratory cells in the center of the cauterization area expressed NOS-II protein. The neovascular response in mice lacking the NOS-II gene was significantly stronger than in wild-type mice, and the difference increased over time.
CONCLUSIONS: These data are the first evidence that NOS-II is expressed in this model of sterile corneal inflammation. NOS-II expression inhibited angiogenesis in severe corneal alkali burns.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10549635

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  5 in total

1.  Inducible nitric oxide synthase mediates the change from retinal to vitreal neovascularization in ischemic retinopathy.

Authors:  F Sennlaub; Y Courtois; O Goureau
Journal:  J Clin Invest       Date:  2001-03       Impact factor: 14.808

2.  Loss of SPARC-mediated VEGFR-1 suppression after injury reveals a novel antiangiogenic activity of VEGF-A.

Authors:  Miho Nozaki; Eiji Sakurai; Brian J Raisler; Judit Z Baffi; Jassir Witta; Yuichiro Ogura; Rolf A Brekken; E Helene Sage; Balamurali K Ambati; Jayakrishna Ambati
Journal:  J Clin Invest       Date:  2006-02       Impact factor: 14.808

Review 3.  Current and emerging therapies for corneal neovascularization.

Authors:  Danial Roshandel; Medi Eslani; Alireza Baradaran-Rafii; Albert Y Cheung; Khaliq Kurji; Sayena Jabbehdari; Alejandra Maiz; Setareh Jalali; Ali R Djalilian; Edward J Holland
Journal:  Ocul Surf       Date:  2018-06-20       Impact factor: 5.033

4.  H-RN, a peptide derived from hepatocyte growth factor, inhibits corneal neovascularization by inducing endothelial apoptosis and arresting the cell cycle.

Authors:  Ye Sun; Li Su; Zhongxiao Wang; Yi Xu; Xun Xu
Journal:  BMC Cell Biol       Date:  2013-02-24       Impact factor: 4.241

5.  Nitric oxide secretion in human conjunctival fibroblasts is inhibited by alpha linolenic acid.

Authors:  Nir Erdinest; Noam Shohat; Eli Moallem; Claudia Yahalom; Hadas Mechoulam; Irene Anteby; Haim Ovadia; Abraham Solomon
Journal:  J Inflamm (Lond)       Date:  2015-10-25       Impact factor: 4.981

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.